Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
08/2006
08/15/2006US7091227 Serine/threonine and tyrosine kinases inhibitors
08/15/2006US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
08/10/2006US20060178360 N(2-hydroxyethyl)-4-methoxy-N,2,6-trimethylbenzene- sulphonamide; analgesic, antiinflammatory agent; hyperalgesia and major algesia connected with other pathological conditions such as cancer
08/09/2006EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
08/09/2006EP1687303A1 4-substituted imidazoles
08/09/2006EP1687302A1 5-substituted imidazoles
08/08/2006US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
08/03/2006WO2005104745A3 Muscarinic acetylcholine receptor antagonists
08/03/2006US20060172984 Methods and compositions of novel triazine compounds
08/01/2006US7084156 2-Aminoquinoline compounds
07/2006
07/27/2006WO2006077419A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s
07/27/2006US20060167042 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation
07/27/2006US20060167002 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
07/27/2006CA2593468A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s
07/26/2006EP1682529A2 Methods for synthesizing quinolinone compounds
07/26/2006EP1513839B1 3-substituted quinuclidines and their use
07/26/2006EP1353919B1 Novel quinuclidine derivatives and medicinal compositions containing the same
07/25/2006US7081531 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists
07/20/2006WO2004108668A3 Alpha-7 neuronal nicotinic receptor ligands: compositions and methods of use
07/20/2006US20060160877 2-Heteroaryl carboxamides
07/19/2006EP1680419A1 Improved aza-bridged-bicyclic amino acid derivatives as a4 integrin antagonists
07/18/2006US7078552 Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs
07/18/2006US7078412 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane in salt form, particularly bromide or trifluoroacetate, for treatment of respiratory disorders, alone or in combination with other bronchodilatory compounds
07/13/2006US20060154988 intracellular inhibition of bacterial polypeptide deformylase in gramnegative bacteria,
07/12/2006EP1679303A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative
07/12/2006EP1678183A1 Spirofuropyridine aryl derivatives
07/12/2006CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
07/05/2006EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
07/05/2006CN1262548C Synthesis of benzoxazine monohydrochlorate compound
07/04/2006US7071216 Anticancer agents
06/2006
06/29/2006WO2006069097A2 Nicotinic alpha-7 receptor ligands and preparation and uses thereof
06/29/2006WO2006067090A1 Novel naphthyl substituted azabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/29/2006US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy
06/29/2006CA2592130A1 Novel naphthyl substituted azabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/29/2006CA2591817A1 Nicotinic alpha-7 receptor ligands and preparation and uses thereof
06/27/2006US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors
06/27/2006US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
06/27/2006US7067506 Compounds useful for inhibiting Chk1
06/27/2006CA2192357C Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
06/22/2006WO2006065233A1 Fused bicycloheterocycle substituted quinuclidine derivatives
06/22/2006WO2006065217A1 Nicotinic acetycholine receptor ligands
06/22/2006WO2006064232A1 Amine salts of (-)-2-((2-(4-hydroxyphenyl)ethyl)thio)-3-(4-(2-(4-((methylsulfonyl)oxy) phenoxy)ethyl)phenyl) propanoic acid
06/22/2006CA2592321A1 Nicotinic acetylcholine receptor ligands
06/22/2006CA2551486A1 Fused bicycloheterocycle substituted quinuclidine derivatives
06/21/2006EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives
06/15/2006US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
06/15/2006US20060128749 Compounds
06/14/2006CN1785997A Pharmaceutical compound, its preparation method and application in making medicine
06/13/2006USRE39128 Antibacteria drug; respiratory system disorders; otitis
06/08/2006WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
06/08/2006WO2006017768A3 Muscarinic acetylcholine receptor antagonists
06/07/2006EP1663220A1 Novel process, salts, compositions and use
06/07/2006CN1784404A Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
06/07/2006CN1784400A Quinuclidine derivatives binding to mucarinic M3 receptors
06/06/2006US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
06/01/2006US20060116395 1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of disease
05/2006
05/31/2006EP1660474A1 Substituted thiophenes and uses thereof
05/31/2006EP1660456A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
05/31/2006EP1660433A2 Preparation and use of alkylating agents
05/31/2006CN1257903C Quinic compound containing quaternary ammonium group and its preparation and medicine use
05/30/2006CA2321380C 6-azauracil derivatives as thyroid receptor ligands
05/26/2006WO2006017767A3 Muscarinic acetylcholine receptor antagonists
05/26/2006WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors
05/24/2006EP1658264A2 Methods and compositions for treating amyloid-related diseases
05/24/2006CN1777577A Antibacterial agents
05/23/2006US7049440 Chemical intermediate for tricyclic compound
05/18/2006US20060106096 6-[(Anilinocarbonyl)amino]-N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzothiophene-2-carboxamide hydrochloride; treatment of dementia, attention deficit hyperactivity disorder and impairments of learning and memory
05/18/2006US20060106058 Chemical compounds
05/18/2006US20060106056 Novel quinuclidine derivatives and medicinal compositions containing the same
05/18/2006US20060106055 Novel quinuclidine derivatives and medicinal compositions containing the same
05/17/2006EP1657239A2 Chromene compound
05/17/2006EP1656375A1 Novel quinuclidine derivatives and their pharmaceutical use
05/17/2006EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same
05/17/2006EP1558252A4 Substituted furo 2,3-b| pyridine derivatives
05/16/2006US7045530 alzheimer's disease; schizophrenia
05/16/2006US7045524 Bactericides; infection therapy; topical administering
05/16/2006CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors
05/11/2006WO2006048225A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
05/11/2006CA2583237A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
05/10/2006EP1655294A2 Chromene compound
05/10/2006EP1655293A2 Chromene compound
05/10/2006CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses.
05/09/2006US7041693 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents
05/09/2006US7041664 e.g., (S)-N-(1-phenylpropyl)-2-(pyrrolidin-1-yl)-quinoline-4-carboxamide in a container with instructions for treating anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder, or pain
05/09/2006CA2238430C Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
05/04/2006WO2006027628A3 Naphthalimide derivatives as antiviral agents
05/04/2006US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same
05/03/2006EP1651645A1 N-biarylamides
05/03/2006EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/03/2006EP1651592A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
05/03/2006EP0937069B1 Piperazino derivatives as neurokinin antagonists
05/03/2006CN1768051A Substituted pyrazoles
04/2006
04/26/2006EP1650207A1 Process for producing optically active 3-quinuclidinols
04/26/2006EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives
04/26/2006CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain.
04/20/2006WO2006040352A1 Novel azabicyclic aryl derivatives and their medical use
04/20/2006WO2006018609A3 Anti-inflammatory agents
04/20/2006US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands
04/20/2006CA2584836A1 Novel azabicyclic aryl derivatives and their medical use
04/19/2006EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 58